GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Live Verdure Ltd (ASX:LV1) » Definitions » Capex-to-Revenue

Live Verdure (ASX:LV1) Capex-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Live Verdure Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Live Verdure's Capital Expenditure for the six months ended in Dec. 2023 was A$0.00 Mil. Its Revenue for the six months ended in Dec. 2023 was A$1.10 Mil.

Hence, Live Verdure's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.00.


Live Verdure Capex-to-Revenue Historical Data

The historical data trend for Live Verdure's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Live Verdure Capex-to-Revenue Chart

Live Verdure Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Capex-to-Revenue
- - - -

Live Verdure Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial - - 0.43 - -

Competitive Comparison of Live Verdure's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Live Verdure's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Live Verdure's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Live Verdure's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Live Verdure's Capex-to-Revenue falls into.



Live Verdure Capex-to-Revenue Calculation

Live Verdure's Capex-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 2.216
=0.00

Live Verdure's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 1.098
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Live Verdure  (ASX:LV1) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Live Verdure Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Live Verdure's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Live Verdure (ASX:LV1) Business Description

Traded in Other Exchanges
N/A
Address
459 Collins Street, Level 21, Melbourne, VIC, AUS, 3000
Live Verdure Ltd is an Australian Health, Wellness and Skincare company making a range of naturally-based products with effective active ingredients. Its products are predominantly sold Direct-to-Consumer (D2C), using the Company's websites. The Company is engaged in providing hemp-based products under 13 seeds brand name. The company focuses on development of Australian hemp food, beauty and nutraceutical products.

Live Verdure (ASX:LV1) Headlines

No Headlines